|
|
Sunday, July 29,
2007
09:00 -
10:15 |
|
HALL
A |
9:00 |
OC OPENING CEREMONY
Chairperson: J.S. Borer,
New York,
NY,
USA
GREETINGS
Asher Kimchi,
USA
Founder and Chairman
International Academy of Cardiology
13th World Congress on Heart Disease
Jeffrey S. Borer, USA
Chairman, Scientific Executive Committee
Chairman, Section of Valvular Heart Disease
International Academy of Cardiology
13th World Congress on Heart Disease
Naranjan S. Dhalla, Canada
Member,
Scientific Executive Committee
Chairman, Section of Cellular Biology of the Heart
International Academy of Cardiology
13th World Congress on Heart Disease
John
A. Elefteriades, USA
Member,
Scientific Executive Committee
Chairman, Section of Cardiovascular Surgery
International Academy of Cardiology
13th World Congress on Heart Disease
Uri
Elkayam,
USA
Member,
Scientific Executive Committee
Chairman,
Section of Heart Failure
International Academy of Cardiology
13th World Congress on Heart Disease
PRESENTATION OF 2007 AWARDS
Jeffrey S. Borer, USA |
|
09:35 -
10:15 |
OL OPENING LECTURE
-
SECOND
H.J.C. SWAN MEMORIAL LECTURE
Chairperson:
U.
Elkayam,
Los Angeles,
CA,
USA |
HALL
A |
9:35 |
INTRODUCTION
U.
Elkayam,
Los
Angeles, CA,
USA |
|
9:40 |
HOW BEST TO IDENTIFY
PATIENTS AT RISK FOR SUDDEN CARDIAC DEATH (Invited Lecture)
M.E. Cain,
University at Buffalo, Buffalo, NY, USA |
|
10:15 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
10:45-13:30 |
|
HALL
A |
|
PL01
Plenary
Session:
CARDIAC REPAIR AND REGENERATION
Chairpersons: J.D. Marsh, Little Rock, AR, USA
T. Toyo-oka, Sendai, Japan |
|
10:45 |
STEM CELLS AND
VASCULAR DISEASES
(Invited Lecture)
Q. Xu,
A. Zampetaki, Cardiovascular
Division, King’s College London, London, UK |
1 |
11:00 |
LONG-LASTING PLASTICITY OF SLOW-TWITCH SKELETAL MYOBLASTS FOR
SELECTIVE
ENGRAFTMENT AND FUNCTIONAL IMPROVEMENT OF FAILING
HEART
(Invited
Lecture)
T. Toyo-oka,
A. Tezuka, T. Kawada, M. Nakazawa, F. Masui, S. Konno, S. NittaTokyo University.
Hospital, & TUBERO, Sendai, Japan |
2 |
11:15 |
MODIFICATION OF CARDIOVASCULAR ION CHANNELS BY GENE THERAPY (Invited
Lecture)
J.D. Marsh,
University
of Arkansas for Medical Sciences, Little Rock, AR, USA |
3 |
11:30 |
HUMAN CARDIOMYOCYTE
PROGENITOR CELLS DIFFERENTIATE INTO FUNCTIONAL CARDIOMYOCYTES IN
VITRO (Invited Lecture)
M-J.Goumans, T.P. de Boer, A.M. Smits, L.W. van Laake, J.P.G. Sluijter,
P. van
Vliet, M.A.G. van der Heyden, G.Pasterkamp, C. L. Mummery,
T.A.B. van Veen,
P.A. Doevendans, University Medical Center,
Heidelberglaan, The Interuniversity Cardiology Institute of the Netherlands, Utrecht,
The Netherlands |
4 |
11:45 |
UNLOCKING THE MYSTERIES
THAT GOVERN VASCULAR CELL LIFE AND CELL LONGEVITY (Invited Lecture)
K. Maiese,
Z.Z. Chong,
Wayne
State University, Detroit, MI, USA |
5 |
12:00 |
SKELETAL MYOBLASTS FOR CHRONIC HEART FAILURE
(Invited Lecture)
P.C. Smits,
Medisch Centrum Rijnmond Zuid, Rotterdam, Netherlands |
6 |
12:15 |
LABELING OF STEM CELLS
FOR NONINVASIVE DELIVERY AND TRACKING IN CARDIOVASCULAR REGENERATIVE
THERAPY (Invited Lecture)
D. Kraitchman,
Johns Hopkins University, Baltimore, MD, USA |
7 |
12:30 |
MYOCARDIAL
RESTORATION WITH STEM CELLS AND BIOARTIFICIAL TISSUES; PANDORA'S BOX
ON THE SCALE (Invited Lecture)
T.
Kofidis,
National University
of Singapore, Singapore |
8 |
12:45 |
NOVEL ENDOGENOUS
MYOCARDIAL REPAIR STRATEGIES FOR THE TREATMENT OF HEART FAILURE (Invited
Lecture)
Y.J. Woo,
University of Pennsylvania, Philadelphia, USA |
9 |
13:00 |
SYSTEMIC INFLAMMATORY CHANGES AND PROGENITOR CELL MOBILIZATION IN
ACUTE MYOCARDIAL INFARCTION (Invited Lecture)
I. Ott,
Deutsches Herzzenrum, Munich, Germany |
10 |
13:15 |
REGULABLE GENE
EXPRESSION SYSTEM FOR ISCHEMIC MYOCARDIUM
W. Zhang,
L.P. Su, L. Ye, E. Sim,
National Heart
Center, Singapore |
11 |
13:30 |
LUNCH BREAK |
|
SUNDAY, JULY
29, 2007 |
10:45-12:15 |
|
HALL
B |
|
PL02 Plenary Session:
TREATMENT OF
CAROTID STENOSIS AND PERIPHERAL VASCULAR DISEASE
Chairpersons:
G.A. Stouffer,
Chapel Hill, NC, USA
T.
Tomaru, Sakura City, Japan |
|
10:45 |
EMBOLIC PROTECTION
DURING CAROTID STENTING WITH THE NEW FIBERNET DEVICE (Invited Lecture)
H. Sievert,
J. Franke,
C.Bauer, V.Woerner, N. Wunderlich, K. Mathias,
J. Schofer,
CardioVascular Center
Frankfurt,
Germany, Washington Hospital DC, USA |
12 |
11:00 |
APPLICATION OF
ANGIOSCOPY FOR DIAGNOSIS AND TREATMENT OF VENOUS THROMBOEMBOLISM
(Invited Lecture)
T. Tomaru,
Toho
University Sakura Hospital, Chiba, Japan |
13 |
11:15 |
NEW INSIGHTS INTO
PERIPHERAL ARTERIAL DISEASE (Invited Lecture)
M.H. Criqui,
University of California, SD, La Jolla, CA, USA |
14 |
11:30 |
THE CHANGING PARADIGM
OF RENAL ARTERY STENOSIS (Invited Lecture)
A. Pathak, M. Rojas,
G.A. Stouffer,
University
of North Carolina, Chapel Hill, NC,
USA |
15 |
11:45 |
INTER-RELATIONSHIP OF
CORONARY ARTERY DISEASE AND PERIPHERAL
ARTERIAL DISEASE (Invited Lecture)
V. Mathew,
Mayo Clinic,
Rochester, MN, USA |
16 |
12:00 |
CAROTID ANGIOPLASTY
UNDER PROTECTION. LIMITATIONS. NEW
DEVELOPMENTS (Invited Lecture)
M. Henry,
A. Polydorou, I. Henry, A. Polydorou, M. Hugel,
Cabinet de Cardiologie, Nancy, France |
17 |
12:15 |
LUNCH BREAK,
VISIT POSTERS AND EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
10:45 - 13:30
|
|
HALL C |
|
PL03 Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
Chairpersons: N.S. Dhalla, Winnipeg, MB, Canada
F.G.
Spinale, Charleston, SC, USA |
|
10:45 |
Beneficial effects of sarpogrelate (an antiplatelet agent) in
congestive heart failure
(Invited Lecture)
N.S. Dhalla,
S.K. Sanganalmath, St. Boniface General Hospital Research Centre,
Winnipeg, Canada |
21 |
11:00 |
DIFFERENTIAL MATRIX METALLOPROTEINASE PROTEOMIC PROFILING IN PATIENTS AT
RISK FOR HEART FAILURE: DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS (Invited
Lecture)
F.G. Spinale,
Medical University of South Carolina, Charleston, SC, USA |
22 |
11:15 |
PLEIOTROPIC EFFECTS OF
CARDIAC DRUGS AND INTERVENTIONS ON THE EXTRACELLULAR COLLAGEN MATRIX:
THE GOOD, BAD AND UGLY (Invited Lecture)
B.I. Jugdutt,
University of Alberta, Edmonton, Alberta, Canada |
23 |
11:30 |
HEAT SHOCK PROTEIN 60
IN HEART FAILURE: FRIEND OR FOE? (Invited Lecture)
L Lin, S.C. Kim, S. Gupta, S.I. Simon, A.A. Knowlton,
University of California,
Davis, VA Medical Center, Sacramento, CA, USA, |
24 |
11:45 |
NATRIURETIC PEPTIDES IN THE APPROACH TO HEART FAILURE
(Invited Lecture)
P.
Bettencourt,
Unidade
Cuidados Intermedios Medicina Hospital, Lisbon, Portugal |
25 |
12:00 |
SERIAL BIOMARKER MEASUREMENTS
(TROPONIN T AND B-TYPE NATRIURETIC PEPTIDE) IN AMBULATORY PATIENTS WITH
CHRONIC HEART FAILURE--WHAT HAPPENS OVER TIME (Invited Lecture)
W.L.
Miller,
K.A. Hartman, D.E. Grill, J.C. Burnett, A.S. Jaffe,
Mayo Clinic, Rochester, MN, USA |
26 |
12:15 |
RISK ASSESSMENT IN
HEART FAILURE (Invited Lecture)
J. Butler,
Emory
University, Atlanta, GA, USA |
27 |
12:30 |
CAN NT-PROBNP LEVELS
HELP PREVENT CARDIOVASCULAR DISEASE (Invited Lecture)
D.J. Campbell,
M. Woodward, J.P. Chalmers, S.A. Colman, A.J. Jenkins, B.E. Kemp, A.
Patel, B.C. Neal, S.W. MacMahon, St. Vincent's
Institute of Medical Research, University of Melbourne, Fitzroy,
Victoria, Australia |
28 |
12:45 |
OBESITY AND HEART
FAILURE: EPIDEMIOLOGICAL CONFUSION AND DIAGNOSTIC DILEMMAS
(Invited Lecture)
H. Dokainish,
Baylor
College of Medicine, Houston, TX, USA |
29 |
13:00 |
MEASURING THE QUALITY
OF HEART FAILURE CARE (Invited Lecture)
P.A. Heidenreich,
Palo Alto VA Health Care System, Palo Alto, CA, U.S.A. |
30 |
13:15 |
CHRONIC APELIN
ADMINISTRATION PREVENTS THE DEVELOPMENT OF LV REMODELING AND DYSFUNCTION
IN RATS WITH HEART FAILURE
Y. Iwanaga,
Y. Tamaki, T. Kita,
Kyoto
University, Kyoto, Japan |
31 |
13:30 |
LUNCH BREAK,
VISIT POSTERS AND EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
10:45 - 13:45 |
|
HALL D |
|
S51
Session:
ATHEROSCLEROSIS: PRIMARY PREVENTION, DIABETES MELLITUS, OBESITY,
METABOLIC SYNDROME
Chairpersons: H. Lazar, Boston, MA, USA
N.D. Wong, Irvine, CA, USA |
|
10:45 |
ACUTE CORONARY SYNDROMES AND DIABETES: IS INTENSIVE LIPID LOWERING
BENEFICIAL? RESULTS OF THE PROVE IT –TIMI 22 TRIAL
S. Ahmed, C.P. Cannon, S.A. Murphy, E. Braunwald,
Sunnybrook Health Sciences Centre University of Toronto, Canada |
32 |
11:00 |
ROLE OF CALRETICULIN IN INDUCING ENDOTHELIAL CELLS DYSFUNCTION IN
DIABETES
Y. Riahi, H.
Totary-Jain, S. Sasson, Hebrew
University
of Jerusalem, Israel |
33 |
11:15 |
HEME OXYGENASE-1 (HO-1) INHIBITS THE DEVELOPMENT OF MYOCARDIAL
DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC CARDIOMYOPATHY IN MOUSE
S. Kiuchi, T.
Morita, T. Suzuki, Y. Yamagishi, J. Tatebe, J. Yamasaki,
Toho University,
Japan |
34 |
11:30 |
IMPACT OF DIABETES ON DISPARITIES IN THE DECLINE OF CARDIOVASCULAR DEATH
RATES: US, 1993 AND 2003
J. Fang, M.H.
Alderman, C. Ayala, N.L. Keenan, J.B. Croft,
Division for Heart Disease and Stroke, CDC, Atlanta,
GA, USA |
35 |
11:45 |
GENDER SPECIFIC PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN LATIN AMERICA: RESULTS
FROM LASO
L.E. Bautista,
V.M. Herrera, J.P. Casas, M. Orostegui, N. Schapochnik, C. Ferreccio, L. Rosero, R. Pichardo, J.R. Sanchez, E. Silva,
University of Wisconsin, Madison, WI, USA |
36 |
12:00 |
PREDICTING CHD/IHD DEATH: METABOLIC SYNDROME VS. FRAMINGHAM SCORE: THE
RANCHO BERNARDO STUDY
E. Barrett-Connor, H. Araneta,
University of California, San Diego, La Jolla, CA, USA |
37 |
12:15 |
ASSOCIATIONS OF BLOOD LEVELS OF INSULIN-LIKE GROWTH FACTOR (IGF)-I, IGF-II
AND IGF-BINDING PROTEIN (IGFBP)-3 WITH CORONARY HEART DISEASE IN ARAB
SUBJECTS
K. Kapila,
A.O. Akanji, Faculty of Medicine,
Kuwait University, Kuwait |
38 |
12:30 |
EFFECT OF ROSIGLITAZONE TREATMENT ON POSTPRANDIAL ENDOTHELIAL DYSFUNCTION
INDICES IN PATIENTS WITH TYPE 2 DIABETES
S. Pastromas,
S. Koulouris, D. Sakellariou, G. Ioannidis, D. Tyousoulis, N. Zakopoulos, A. Nikou, Ch. Stefanadis, A.S. Manolis,
Evagelismos General Hospital Athens, Athens |
39 |
12:45 |
MODERATE OR SEVERE RENAL INSUFFICIENCY IS ASSOCIATED WITH 3-VESSEL
CORONARY ARTERY DISEASE
O. Khalique,
W.I.S. Aronow, C. Ahn, M. Mazar, B. Schair, J. Shao, V. Channamsetty,
New
York
Medical College, Valhalla, NY, USA |
40 |
13:00 |
ACUTE OUTCOME AND LONG-TERM RESULTS OF CAROTID STENTING UP TO 11 YEARS: A
COMPARISON OF DIABETIC AND NON-DIABETIC PATIENTS
J.
Franke,
V. Woerner, C. Bauer, S. Ghasemzadeh-Asl, M. Koch, C. Thomalske, U.
Oetjen, P. Schneider, N. Wunderlich, H. Sievert,
CardioVascular Center Frankfurt,
Germany |
41 |
13:15 |
EPICARDIAL ADIPOSE TISSUE IS RELATED TO CAROTID INTIMA-MEDIA THICKNESS
AND VISCERAL ADIPOSITY IN HIV- INFECTED PATIENTS WITH HIGHLY ACTIVE
ANTIRETROVIRAL THERAPY-ASSOCIATED METABOLIC SYNDROME
G. Iacobellis, A.M. Pellicelli, B. Grisorio, G. Barbarini, A.M.
Sharma, G. Barbaro,
Policlinico S.Matteo, Pavia, Italy |
42 |
13:30 |
EFFECTS OF ACE2 GENE TRANSFER ON THE EXPRESSION OF MIF IN HUMAN
ENDOTHELIAL CELLS
J.C. Zhong,
X.Y. Yu, X.H. Li, Q.X. Lin, X.Z. Huang, S.G. Lin,
Guangdong Provincial People’s Hospital, Guangzhou,
Guangdong, China |
43 |
13:45 |
LUNCH BREAK,
VISIT POSTERS AND EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
14:00 - 16:15 |
|
HALL
A |
|
PL04 Plenary Session:
RISK
STRATIFICATION FOR SUDDEN CARDIAC DEATH
Chairpersons: M. Cain, Buffalo, NY, USA
J.E. Madias, Elmhurst, NY, USA |
|
14:00 |
REPRODUCIBILITY OF
T-WAVE ALTERNANS IN PATIENTS WITH CHF (Invited Lecture)
J. Madias,
Mount Sinai School of Medicine of the New York/Cardiology Division,
Elmhurst Hospital Center, USA |
107 |
14:15 |
PUBLIC ACCESS DEFIBRILLATION IN OUT-OF-HOSPITAL CARDIAC ARREST THE PIACENZA PROGETTO
VITA RESULTS
A.
Capucci,
D. Aschieri, G.Q. Villani, M. Piepoli, A. Rosi, M.S. Pisati,
C. Armentano,
Piacenza Hospital,
Italy |
108 |
14:30 |
POPULATION-BASED ANALYSIS OF SUDDEN CARDIAC DEATH: CLINICAL IMPLICATIONS
(Invited Lecture)
S.S. Chugh,
Oregon
Health & Science University, Portland, Oregon, USA |
109 |
14:45 |
FLUCTUATIONS OF ECG AND RISK STRATIFICATION IN BRUGADA SYNDROME (Invited
Lecture)
M. Takagi, H.
Tatsumi,
Osaka City
University Graduate School of Medicine, Osaka, Japan |
110 |
15:00 |
SUDDEN CARDIAC DEATH IN YOUNG INDIVIDUALS: CLINICAL AND GENETIC
INVESTIGATION OF THE FAMILY (Invited Lecture)
P.P.
McKeown,
Royal
Hospitals Trust and Queen's University, Belfast, UK |
111 |
15:15 |
SYNCOPE OF UNKNOWN
ORIGIN: CONTROL OF THE DRUG THERAPY EFFICACY BY TILT TEST REPETITION
(Invited Lecture)
D. Flammang,
G. Chauveau, S. Mousi, Lyon University Hospital, Lyon, France |
113 |
15:30 |
IS IT POSSIBLE TO REDUCE HOSPITALIZATION COSTS FOR PATIENTS CONSIDERED AT
RISK OF SERIOUS ARRHYTHMIAS?
(Invited
Lecture)
A. Martinez Rubio,
S. Galan, M. Cazorla, E. Guillaumet, S. Ibars, E. Guilera, M. Bonastre,
R. Baga, G. Gusi, I. Anguera, Hosp de
Sabadell, Spain |
114 |
15:45 |
CURRENT PERSPECTIVES IN
RISK STRATIFICATION FOR SUDDEN CARDIAC DEATH (Invited Lecture)
D. Wichterle,
Institute for Clinical and Experimental Medicine, Prague,
Czech Republic |
115 |
16:00 |
OBESITY,
PHYSICAL ACTIVITY AND SUDDEN CARDIAC ARREST
P.R. Reddy, K. Reinier, C. Socoteanu, R. Mariani, S.S.
Chugh, Oregon
Health and Science University, Portland, OR, USA |
116 |
16:15 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
14:00 - 16:15 |
|
HALL
B |
|
PL05
Plenary Session:
NEW
DEVELOPMENTS IN CARDIAC IMAGING
Chairpersons:
S.
Dalla-Volta,
Padova, Italy
|
|
14:00 |
A
COMPARISON BETWEEN CORONARY ANGIOGRAM AND MULTISLICE CT IN CORONARY
ARTERY DISEASE. A STUDY OF 150 CASES (Invited Lecture)
P. Greco,
S. Romano, M. Del-Borrello,
S. Dalla-Volta,
with technical collaboration of Luigi Baracchino,
Euganea Medica Cardiac Imaging Laboratory, Padova, Italy |
117 |
14:15 |
CONCERNING CORONARY
ARTERY CALCIUM (Invited Lecture)
E. Barrett-Connor,
University
of California, San Diego (UCSD), La
Jolla, CA, USA |
119 |
14:30 |
CORONARY ARTERY BYPASS GRAFTS AND CT ANGIOGRAPHY
(Invited Lecture)
L. Kritharides,
Concord Hospital, University of Sydney, Australia |
120 |
14:45 |
REAL-TIME 3D ECHOCARDIOGRAPHY 2007 (Invited Lecture)
F.J. Ten Cate,
Erasmus MC, Rotterdam,
The Netherlands
|
121 |
15:00 |
MDCT OF CARDIOVASCULAR DISEASE: PRESENT STATUS & FUTURE PROSPECTS
(Invited Lecture)
J. Lima,
Johns Hopkins
University, Baltimore, MD, USA |
122 |
15:15 |
THE FUTURE OF STRESS PERFUSION IMAGING IN THE ERA OF CT
(Invited Lecture)
R. Hachamovitch,
University
of Southern California, Los Angeles, CA, USA |
123 |
15:30 |
REVASCULARIZATION IN LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: THE ROLE OF
VIABILITY TESTING (Invited Lecture)
P. Chareonthaitawee,
Mayo Clinic and Mayo Clinic
College of Medicine, Rochester, MN, USA |
124 |
15:45 |
ECHOCARDIOGRAPHY OF THE
SUPERIOR VENA CAVA (SVC): CURRENT STATUS 2007
R.N. Khouzam,
D. Minderman, I.A. D'Cruz,
University of Tennessee
Health Science Center, Memphis, TN, USA |
125 |
16:00 |
IMPROVED YIELD OF
TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN STROKE PATIENTS IS MAINLY LIMITED TO AORTIC
PLAQUE AND INTRACARDIAC SHUNT
D.M. Spevack, D. Malhotra, S. Doddamani,
R.J. Ostfeld,
E. Altman,
G.M. Gordon,
Montefiore
Medical Center, Bronx, NY, USA |
127 |
16:15 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
14:00 - 16:15 |
|
HALL C |
|
PL06
Plenary
Session:
INFLAMMATION AND
ATHEROGENESIS
Chairpersons:
J.G. Filep,
Montreal, Canada
I. Jialal, Sacramento, CA,
USA
|
|
14:00 |
C-REACTIVE PROTEIN
PROMOTES ATHEROTHROMBOSIS (Invited Lecture)
I.
Jialal,
UC
Davis Medical Center, Sacramento CA, USA |
129 |
14:15 |
DOES C-REACTIVE PROTEIN ORCHESTRATE INFLAMMATION IN ACUTE CORONARY ARTERY
DISEASE? (Invited Lecture)
J.G. Filep,
L. Jozsef, L.A. Potempa, T. Khreiss,
Maisonneuve-Rosemont
Hospital, University of Montreal, QC, Canada |
130 |
14:30 |
THE INFLAMMATORY RESPONSE IN THE NEONATE AND ITS MANAGEMENT (Invited
Lecture)
T.F. Feltes,
Ohio
State University, Columbus Children's Hospital, Ohio,
USA |
131 |
14:45 |
IMMUNE RESPONSE TO OXLDL AND ITS IMPACT IN ATHEROSCLEROSIS (Invited
Lecture)
X. Zhou,
Karolinska
Hospital, Stockholm, Sweden |
132 |
15:00 |
MOLECULAR IMAGING OF
ATHEROSCLEROTIC PLAQUE INFLAMMATION (Invited
Lecture)
M.
Aikawa,
Brigham and Women’s Hospital and Harvard Medical School,
Boston, MA, USA
|
133 |
15:15 |
PROSTANOIDS AND
ISOPROSTANOIDS IN ATHEROGENESIS (Invited
Lecture)
D. Pratico,
University of Pennsylvania, Philadelphia, USA |
134 |
15:30 |
ORIGIN OF LOW-GRADE
SYSTEMIC INFLAMMATION (Invited Lecture)
D.
Aronson,
Rambam
Medical Center, Haifa, Israel |
135 |
15:45 |
THE ROLE OF ANTIGEN-PRESENTING CELLS IN CARDIOVASCULAR DISEASE: A
POTENTIAL THERAPEUTIC TARGET? (Invited Lecture)
A. Niessner,
Medical University of Vienna,
Austria |
136 |
16:00 |
CYBA C242T GENE POLYMORPHISM IS ASSOCIATED WITH THE LEVEL OF
C-REACTIVE-PROTEIN (CRP) IN A POPULATION OF YOUNG HEALTHY FINNS
M. Fan, O.T.
Raitakari, M. Kahonen, M. Juonala, N. Hutri-Kahonen, J. Marniemi, J. Viikari, T. Lehtimaki,
Tampere
University Hospital and Medical School at the
University of Tampere, Finland |
137 |
16:15 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
14:00 - 16:30 |
|
HALL D |
|
S52
Session:
SECONDARY
PREVENTION, MODIFICATION OF LIPOPROTEINS, PROGNOSIS, RISK
STRATIFICATION
Chairpersons: S-O. Olofsson, Goteborg, Sweden
R.S. Rosenson, Ann Arbor, MI,
USA |
|
14:00 |
DOSE-DEPENDENT REDUCTIONS IN LDL-C WITH ISIS 301012, AN
ANTISENSE INHIBITOR OF APOLIPOPROTEIN B
D.L. Tribble,
M.K. Wedel, B.F. Baker, E. Stein, R. Fuhr, J.W. Jukema,
E.
Sijbrands, M. Trip, F. Visseren, R. Weiss, F. Akdim, J.J.P. Kastelein,
Isis Pharmaceuticals Inc, Carlsbad,
CA, USA |
138 |
14:15 |
STATIN USE BEFORE AND AFTER STROKE ONSET IMPROVES OUTCOME OF ACUTE
ISCHEMIC STROKE
M. Moonis, K.
Kane, M. Fisher,
UMass
Medical Center, Worcester, MA, USA |
139 |
14:30 |
GLOMERULAR FILTRATION
RATE AT CARDIAC CATHETERIZATION PREDICTS FUTURE ADVERSE CARDIAC EVENTS
S.S. Brar, K. Ellini, V.J. Aharonian, P. Mansukhani, I.L. Liu,
A.Y.J. Shen,
Kaiser Permanente
Medical Center, Los Angeles, CA, USA |
140 |
14:45 |
IMPACT OF ROUTINE
IN-HOSPITAL ASSESSMENT OF LDL LEVELS AND LIPID LOWERING THERAPY IN
PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
M. Ahmad, J-D.R. Schwalm, J.L.Velianou, M.K. Natarajan,
McMaster
University and Hamilton Health Sciences, Hamilton, Ontario, Canada |
141 |
15:00 |
RECURRENT ANGINA FOLLOWING REVASCULARIZATION
J.A. Kempf,
S. Shetty, M.A. Nelson, M. Sweeney, CV
Therapeutics,
Palo Alto,
CA. USA |
142 |
15:15 |
BLUEBERRY-ENRICHED DIET PROTECTS HEART FROM ISCHEMIC DAMAGE
I. Ahmet, E. Spangler, B. Shukitt-Hale, J. Joseph, D.K. Ingram, M.I.
Talan,
National Institute on Aging, Baltimore,
MD, USA |
143 |
15:30 |
THE IMPACT
OF SEXUAL THERAPY ON PATIENTS AFTER CARDIAC EVENTS PARTICIPATING IN
MULTI-DISCIPLINARY CARDIAC REHABILITATION PROGRAM
J.
Klein,
R. Klein, E. Bar-on, R. Bebenishty, Shaare Zedek Medical Center,
Jerusalem, Israel |
144 |
15:45 |
COMPARATIVE EFFECT OF NITRATES AND TRIMETAZIDINE PLUS SILDENAFIL ON
EXERCISE-INDUCED MYOCARDIAL ISCHEMIA. IMPLICATIONS FOR PATIENTS
WITH ERECTILE DYSFUNCTION
G. Marazzi, C. Vitale, M. Miceli, G. Caminiti, L.Gatta, C. Mammi, M.
Volterrani, G. Rosano, IRCCS San
Raffaele
Roma, Italy |
145 |
16:00 |
ACCURACY OF RATIO OF TRIGLYCERIDE TO HDL IN PREDICTING HDL PARTICLE SIZE
IN ASIAN INDIANS
N.C. Bhalodkar, S Blum, R Singh, E.A. Enas,
Albert Einstein College of Medicine, Bronx,
NY, USA |
146 |
16:15 |
INFLAMMATORY PROTEINS AND DEPRESSION AFTER CORONARY STENTING PREDICT MAJOR
ADVERSE CORONARY EVENTS
L. Frazier,
W.K. Vaughn, J.T. Willerson, C.M.
Ballantyne, E.
Boerwinkle,
University
of Texas at Houston, Texas, USA |
147 |
16:30 |
COFFEE BREAK, VISIT POSTERS & EXHIBITION |
|
SUNDAY, JULY
29, 2007 |
16:45-19:15 |
|
HALL
A |
|
PL07
Plenary Session:
NEW CONCEPTS
IN TRANSLATIONAL CARDIAC RESEARCH
Chairpersons: J. Nilsson, Malmo,
Sweden
R. Roberts, Ottawa, ON, Canada |
|
16:45 |
PURSUING GENES THAT
CONTRIBUTE TO CORONARY ARTERY DISEASE – AN IDEA WHO’S TIME HAS COME
(Invited Lecture)
R.
Roberts,
University of Ottawa Heart Institute, Ontario, Canada |
150 |
17:00 |
LIPOPROTEIN AUTOIMMUNITY AS A NOVEL TARGET FOR TREATMENT OF
CARDIOVASCULAR DISEASE (Invited Lecture)
J. Nilsson,
Lund University,
Malmo, Sweden |
151 |
17:15 |
CLINICAL GENOMIC AND PROTEOMIC APPROACHES TO UNDERSTAND CARDIOVASCULAR
DISEASE (Invited Lecture)
C. Patterson,
University
of North Carolina at Chapel Hill, NC, USA |
152 |
17:30 |
STRUCTURAL BIOLOGICAL APPROACH TO CARDIOVASCULAR DISEASE (Invited
Lecture)
H. Mori,
National Cardiovascular Center Research Institute, Suita,
Osaka, Japan |
153 |
17:45 |
SELECTIVE NUCLEAR RECEPTOR MODULATION IN CARDIOMETABOLIC DISEASE (Invited
Lecture)
U. Kintscher,
Charite-Universitaetsmedizin Berlin, Germany |
154 |
18:00 |
COMPREHENSIVE APPROACHES FOR IDENTIFICATION OF SUSCEPTIBILITY GENES TO
MYOCARDIAL INFARCTION (Invited Lecture)
M. Yokota,
Aichi-Gakuin University, Nagoya, Japan |
155 |
18:15 |
PARALLELS BETWEEN THE NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES
(Invited Lecture)
J.
Robbins,
Cincinnati Children's Hospital, OH, USA |
156 |
18:30 |
PHARMACOLOGICAL INHIBITION OF EPSILON PKC PREVENTS THE PROGRESSION OF
HYPERTENSION-INDUCED HEART FAILURE IN RATS (Invited Lecture)
K. Inagaki, T. Koyanagi, D.
Mochly-Rosen, Stanford University School
of Medicine, Stanford, CA, USA |
157 |
18:45 |
ENDOGENOUS SECRETORY RAGE: A POTENTIAL TARGET FOR CARDIOVASCULAR DISEASES
AND METABOLIC SYNDROME (Invited Lecture)
H. Koyama,
H.Yamamoto, Y. Nishizawa,
Osaka
City University Graduate School of Medicine, Osaka, Japan |
159 |
19:00 |
MOLECULAR IMAGING IN
CARDIOVASCULAR DISEASES (Invited Lecture)
E. Aikawa,
Massachusetts General Hospital and Harvard Medical School, MA, USA |
160 |
SUNDAY, JULY
29, 2007 |
16:45
- 19:30 |
|
HALL
B |
|
PL08 Plenary
Session:
MODIFICATION OF RISK FACTORS AND CAD, DYSLIPOPROTEINEMIA, HYPERTENSION,
DIABETES MELLITUS AND METABOLIC SYNDROME
Chairpersons: H. Boudoulas, Athens, Greece
C. Rosendorff, Bronx, NY, USA |
|
16:45 |
HOW LOW IS TOO LOW? IS THERE A
LIMIT TO BLOOD PRESSURE LOWERING? (Invited Lecture)
C.
Rosendorff,
Mount
Sinai School of Medicine and the JJ Peters VA Medical Center, New York,
NY, USA |
161 |
17:00 |
ASSOCIATION BETWEEN GLYCOSYLATED HEMOGLOBIN, LEFT VENTRICULAR MASS AND
AORTIC FUNCTION IN NON DIABETIC INDIVIDUALS WITH INSULIN RESISTANCE
(Invited Lecture)
H. Boudoulas,
Biomedical Research Foundation, Academy of Athens, Greece |
162 |
17:15 |
VASCULAR SIGNALING IN HYPERTENSION - CURRENT CONCEPTS AND FUTURE (Invited
Lecture)
R.M. Touyz,
Ottawa Health Research Institute, University of Ottawa, Ottawa, ON,
Canada |
163 |
17:30 |
IMPACT OF METABOLIC SYNDROME ON LEFT VENTRICULAR MASS AND GEOMETRY IN
YOUNG ADULTS: THE BOGALUSA
HEART STUDY
(Invited Lecture)
D.A. Patel, S.R. Srinivasan, W. Chen, E. McIlwain, G.S. Berenson,
Tulane
Center for Cardiovascular Health, Tulane University, New Orleans, LA,
USA |
164 |
17:45 |
LIPID STORAGE IN CELLS; MECHANISM AND IMPLICATIONS FOR CARDIOVASCULAR
DISEASES (Invited Lecture)
S.O. Olofsson,
Department of Medicine, Goeteborg,
Sweden |
165 |
18:00 |
BENEFITS OF TIGHT
GLYCEMIC CONTROL DURING CORONARY REVASCULARIZATION (Invited Lecture)
H.L.
Lazar,
Boston
Medical Center, MA, USA |
166 |
18:15
|
METABOLIC SYNDROME, SUBCLINICAL ATHEROSCLEROSIS AND CARDIOVASCULAR RISK
(Invited Lecture)
N.D. Wong,
University of California, Irvine, CA, USA |
167 |
18:30
|
TARGETING LIPOPROTEIN SUBCLASS ABNORMALITIES IN THE METABOLIC SYNDROME:
NEW OPPORTUNITIES FOR CARDIOVASCULAR RISK REDUCTION
R.S. Rosenson,
University
of Michigan, Ann Arbor, MI, USA |
168 |
18:45 |
AGGRESSIVE LIPID
MANAGEMENT: LDL APHERESIS (Invited Lecture)
D. Polk,
Division of Cardiology
Cedars-Sinai Medical Center, Los Angeles, CA, USA |
169 |
19:00 |
CLINICAL GUIDELINES FOR THE PRIMARY PREVENTION OF HYPERTENSION: CAN WE DO
MORE? (Invited Lecture)
H.D. Sesso,
Brigham and Women's Hospital, Boston, MA,
USA |
170 |
19:15 |
MEDITERRANEAN DIET
AND CORONARY HEART DISEASE, IS OBESITY A LINK? (Invited Lecture)
D.B.
Panagiotakos,
Harokopio
University of Athens, Greece |
172 |
SUNDAY, JULY
29, 2007 |
16:30
- 19:15 |
|
HALL
C |
|
S53
Session:
NEW INSIGHTS
INTO THE PATHOGENESIS AND MANAGEMENT OF HEART FAILURE, PULMONARY
CIRCULATION ASPECTS
Chairpersons: T. Force, Philadelphia, PA, USA
B.I. Jugdutt, Edmonton, Alberta,
Canada |
|
16:30 |
PULMONARY ARTERIAL HYPERTENSION (PAH) IN MICE LACKING THE VASOACTIVE
INTESTINAL PEPTIDE (VIP) GENE
S.I. Said,
S.A. Hamidi, K.G. Dickman, A.M. Szema, S. Lyubsky, R.Z. Lin, Y.P. Jiang, J.J. Chen, J.A. Waschek, S. Kort,
SUNY at Stony Brook, Stony Brook, NY and VA Medical Center, Northport,
NY, USA |
173 |
16:45 |
THE EFFECT OF INHALED MILRINONE ON PULMONARY HYPERTENSION IN PATIENTS
UNDERGOING CARDIAC SURGERY, A PILOT RANDOMIZED STUDY
A.Y. Denault, F. Haddad, Y. Lamarche, P. Couture, J.C. Tardif, L.
Perrault,
Montreal Heart Institute, Montreal, Quebec, Canada |
174 |
17:00 |
SINUS TACHYCARDIA
PREDICTS INCREASED MORTALITY IN CHRONICALLY TREATED HEART FAILURE
PATIENTS
C.A.
Dragstedt,
D.F. Pauly, R.S. Schofield, J.A. Hill, J.M.A. Aranda Jr., University of Florida
College of Medicine, Gainesville, FL, USA |
175 |
17:15 |
REDUCTION OF GAP JUNCTION PROTEINS AND INTERCALATED DISC STRUCTURAL
REMODELING IN THE HEARTS OF MICE SUBMITTED TO SEPSIS
M.R. Nunes-Celes, D. Tores-Dueñas, F.Q. Cunha, M.A. Rossi,
University of São Paulo, Ribeirão Preto, São Paulo, Brazil |
176 |
17:30 |
STATINS AND WHITE BLOOD CELL COUNT PREDICT MORTALITY IN PATIENTS WITH
ISCHEMIC LEFT VENTRICULAR DYSFUNCTION UNDERGOING PERCUTANEOUS CORONARY
INTERVENTION
M.J. Lipinski,
A. Abbate, M.J. Cowley, E. Goudreau, W.N. Malloy, G.W. Vetrovec,
University
of Virginia Health System and Virginia Commonwealth University Health
System, VA, USA |
177 |
17:45 |
“SHIFT”: HEART RATE
SLOWING FOR HEART FAILURE
J.S.
Borer,
Weill Medical College of Cornell University, New York, NY, USA |
178 |
18:00 |
THE EFFECT OF HEMODIALYSIS SESSION ON P WAVE DISPERSION IN PATIENTS WITH
CHRONIC HEMODIALYSIS
B. Ozben, M. Sumerkan, S.U. Kefeli, A.S. Fak, A.Toprak, M. Koc,
N. Papila, M.A. Tanrikulu, A.O. Baykan, A.A. Cincin,
Marmara
University Faculty of Medicine, Istanbul, Turkey |
179 |
18:15 |
RESULTS OF RADICAL RESECTION OF PRIMARY MAIN PULMONARY ARTERY SARCOMA
S.H. Blackmon, D.C. Rice, A.M. Correa, D.A. Ott, J.B. Putnam, W.R. Smythe, A.A. Vaporciyan, J.C. Walkes, G.L. Walsh, M.J. Reardon,
The
Methodist Hospital and M.D. Anderson Cancer Center, Texas, USA |
180 |
18:30 |
PROGNOSTIC VALUE OF PACING-INDUCED MECHANICAL ALTERNANS IN PATIENTS WITH
MILD TO MODERATE IDIOPATHIC DILATED CARDIOMYOPATHY IN SINUS RHYTHM
A. Hirashiki,
H. Izawa, T. Murohara, M.Yokota,
Nagoya
University Graduate School of Medicine, Nagoya, Japan |
181 |
18:45 |
FABRY’S DISEASE: CORONARY SMALL VESSEL OBSTRUCTION AS A CAUSE OF
MYOCARDIAL ISCHEMIA AND DISEASE PROGRESSION
C. Chimenti,
E. Morgante, G. Tanzili, R. Verardo, F. Toscano, C. Gaudio,
M.A. Russo, A.
Frustaci,
La
Sapienza University, Rome, Italy |
182 |
19:00 |
THE PREVALENCE,
CLINICAL CHARACTERISTICS, AND PROGNOSIS OF 519 ELDERLY PATIENTS WITH
HEART FAILURE AND PRESERVED SYSTOLIC FUNCTION. A CLINICAL STUDY
WITH A 5 YEARS FOLLOW-UP PERIOD
F. El Shaer,
W. Hassan, N. ElKum, M. Fawzy, M. Nawaz, S. Khrabshah, N. AKhras, C.
Canver, KFSH&RC, Saudi Arabia |
183 |
SUNDAY, JULY
29, 2007 |
16:45
- 19:30 |
|
HALL
D |
|
S54
Session:
INTERVENTIONAL
CARDIOLOGY
Chairpersons: V. Mathew, Rochester, MN, USA
H. Mudra, Munchen,
Germany |
|
16:45 |
REDUCTION OF MYOINTIMAL HYPERPLASIA AFTER ARTERIAL ANASTOMOSIS BY LOCAL
INJECTION OF TGF BETA 3
J. Ghosh,
M.S. Baguneid, M.O. Murphy, N. Khwaja, N. Turner, A. Halka, A. Carter, M.W. Ferguson, C.M. Kielty, M.G.Walker,
Manchester
Royal Infirmary, UK |
184 |
17:00 |
EFFICACY AND SAFETY OF DOUBLE AND TRIPLE ANTIPLATELET THERAPY IN NON ST
ELEVATION MYOCARDIAL INFARCTION
J.A. Marin-Neto, G.B. Marin, W.J. Rogers,
University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil |
185 |
17:15 |
RENAL TOXICITY EVALUATION AND COMPARISON BETWEEN IODIXANOL AND HEXABRIX IN
PATIENTS WITH RENAL INSUFFICIENCY UNDERGOING CORONARY ANGIOGRAPHY-THE
RECOVER STUDY: A RANDOMIZED CONTROLLED TRIAL
S.H. Jo, H.S.
Kim, B.K. Koo, T.J. Youn, H.J. Kang, Y.J. Kim, D.W. Sohn, B.H.Oh, Y.B.
Park, Y.S. Choi,
Hallym
University Sacred Heart Hospital, Gyeonggi-do, Korea |
186 |
17:30 |
THE NORDIC BIFURCATION
STUDY, 14 MONTHS DATA
T.K. Steigen,
M. Maeng, R. Wiseth, A. Erglis, I. Kumsars, I. Narbute, P. Gunnes, J.
Mannsverk, J.F. Lassen, L. Thuesen,
University Hospital of Northern Norway, Tromsoe, Norway |
187 |
17:45 |
RENAL ANGIOPLASTY AND STENTING UNDER EMBOLIC PROTECTION DEVICES. A MUST?
M. Henry,
A.Polydorou, I.Henry, A. Polydorou, M.Hugel,
Cabinet de Cardiologie,
Nancy, France |
188 |
18:00 |
ENDOVASCULAR
THERAPY OF CHRONIC MESENTERIC ISCHAEMIA
A.G.
Daige,
R.G. Wanderley, R.B. Favero, L.E. Pereira, I.S. Nunes, L.Z.
Kanashiro, Santa Casa, Campo Grande, MS,
Brazil |
189 |
18:15 |
BOTH SIDES CORONARY ANGIOGRAPHY AND INTERVENTION USING A SINGLE
TRANSRADIAL GUIDING CATHETER
A.A. Youssef,
Y.K. Hsieh, C.I. Cheng, C.J. Wu,
Chang Gung
University College of Medicine, Kaohsiung, Taiwan, R.O.C. |
190 |
18:30 |
Mid-term comparison between Drug Eluting Stents
(DES) and surgical treatment of patients with Diabetes Mellitus
Y.
Ben-Gal, B. Medalion, Y. Moshkovitz, I. Herz, N. Hansson, G. Uretzky,
R. Mohr, Tel Aviv Sourasky Medical Center,
Tel Aviv, Israel |
191 |
18:45 |
SAFETY AND EFFICACY OF TRIPLE ANTIPLATELET PHARMACOTHERAPY INCLUDING
GLYCOPROTEIN IIB/IIIA RECEPTOR BLOCKERS IN ELDERLY PATIENTS RECEIVING
DRUG-ELUTING STENTS
V.N. Singh,
R.K. Sharma, M. Nelson,
University of South Florida College of Medicine, Tampa, FL, USA |
192 |
19:00 |
ARE DRUG ELUTING STENTS SAFE IN THE ELDERLY?
M. Behan, G.
Dixon, L. Blows, N. Pareek, D. Hildick-Smith, S. Holmberg, A. deBelder, Sussex Cardiac Centre,
Brighton, Sussex, UK |
193 |
19:15 |
PRIMARY AND RESCUE PERCUTANEOUS CORONARY INTERVENTION WITH PACLITAXEL-ELUTING
STENT IMPLANTATION IN ST-ELEVATION MYOCARDIAL INFARCTION
J.D. Schwalm,
M. Ahmad, J.L. Velianou, C. Xie, M.K. Natarajan,
McMaster
University, Hamilton General Hospital, Hamilton, ON, Canada |
194 |
|
|